Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., Barnason, S.A., Beckman, J.A., et al. (2015) 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of Nuclear Cardiology, 22, 162-215.
https://doi.org/10.1007/s12350-014-0025-z

has been cited by the following article:

• TITLE: Effect of Non-Routine Perioperative Laboratory Values on 30 Day Mortality after Non-Cardiac Surgery

  AUTHORS: Michael Ohebsion, Zhongjie Cai, Alexandra Ruan, Stephanie Biglarian, Ling Zheng, Mary M. Joseph

  KEYWORDS: Laboratory Values, Perioperative, Non-Routine, 30 Day Mortality

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.7 No.6, June 28, 2017

  ABSTRACT: Background: It is known that certain laboratory value abnormalities may increase mortality in patient populations with specific risk factors and specific procedures. The purpose of this paper was to investigate the effect of drawing a non-routine lab (regardless of its result) on 30 day mortality and to investigate the effect of an abnormal non-routine laboratory value on 30 day mortality. Methods: The electronic medical records of adult patients undergoing non-cardiac surgery from 2011-2014 at LAC + USC Medical Center were reviewed retrospectively as approved by our institutional review board. Demographic data, surgical risk assessment, and routine and non-routine laboratory values (TSH, Troponin, Creatine Kinase, Hb A1c) were recorded; patients were grouped according to the single non-routine lab they had drawn. Multivariate logistic regression analysis was used to determine significant risk factors associated with increased 30 day mortality. Results: 11,306 patients met our inclusion criteria. Drawing a non-routine lab was associated with a statistically significant increase in mortality in the Troponin group (OR = 3.05, P